regulatory

News

Boehringer Ingelheim's oral HER2 inhibitor zongertinib has started an FDA review as a lung cancer treatment with a decision due in the third quarter.

News

Gilead's already dominant position in HIV PrEP could be extended if the FDA approves a new twice-yearly injectable product later this year.

News

Recently hired employees of the FDA and CDC look set to be the latest workers affected by sweeping job cuts implemented by the Trump administration.

News

New HHS Secretary RFK Fr has been given the task of investigating child health in the US, including whether some medicines may pose a threat.

News

The US Senate today confirmed Robert F Kennedy Jr as Health and Human Services Secretary, after a vote that largely followed party lines.

R&D

In a new podcast, pharmaphorum speaks with two PharmaLex experts about navigating complex R&D processes to unleash the next wave of biopharma.